Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smartwatch help rural seniors age better? taiwan launches landmark study

NCT ID NCT07232667

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to help older adults in rural Taiwan live healthier lives by using wearable devices and a mobile app to track activity, sleep, and other health measures. Researchers will work with 140 participants to see if this technology can improve health literacy and identify early signs of cognitive or physical decline. The goal is to build a digital database that can predict and prevent age-related health problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes community-dwelling and outpatient older adults who are recruited through clinical services, community outreach, and research-related activities at China Medical University Beigang Hospital. Eligible participants are older adults who are willing to participate in the study and able to complete clinical assessments, cognitive evaluation, blood sample collection, and wearable device monitoring.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Currently living or receiving care in a stable environment for at least four weeks prior to enrollment: * For community-based participants: must have resided at the same address for ≥4 weeks. * For day-care participants: must have attended activities at the same dementia or elderly day-care center for ≥4 weeks. 2. Able and willing to participate in the study procedures. 3. Informed consent must be obtained before participation. * If the participant's cognitive function has declined to a level that prevents self-consent, written consent will be obtained from a legally authorized representative or primary caregiver. Exclusion Criteria: 1. Unstable physical or psychological condition that makes participation unsafe, as determined by a clinical investigator - e.g., acute delirium or current respiratory infection (including COVID-19). 2. Any known allergy or skin sensitivity to the materials used in the Geneactiv actigraphy device or iCue sensor pad. 3. Any other medical, neurological, or behavioral condition deemed unsuitable for participation by the study physician.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digital health literacy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • China Medical University Beigang Hospital

    RECRUITING

    London, Alabama, WC1N 2AN, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.